Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening in patients with diabetes mellitus: A systematic review and meta-analysis

JAMA Internal Medicine

Volumn 174, Issue 7, 2014, Pages 1108-1115

  Wu, Hon Yen ^a,b,c   Peng, Yu Sen ^a,b   Chiang, Chih Kang ^b   Huang, Jenq Wen ^b   Hung, Kuan Yu ^b   Wu, Kwan Dun ^b   Tu, Yu Kang ^c   Chien, Kuo Liong ^b,c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ALBUMIN BLOOD LEVEL; ALBUMIN CONCENTRATION; ALBUMIN TO CREATININE RATIO; ARTICLE; CREATININE URINE LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MICROALBUMINURIA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; URINALYSIS; URINE;

ALBUMINURIA; CREATININE; DIABETES COMPLICATIONS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84903618995     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.1363     Document Type: Article

References (41)

1. KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2) (suppl 2):S12-S154.
2. Wu HY, Huang JW, Lin HJ, et al. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes. BMJ. 2013;347:f6008.
3. MacLeod JM, Lutale J, Marshall SM. Albumin excretion and vascular deaths in NIDDM. Diabetologia. 1995;38 (5):610-616.
4. Wu HY, Huang JW, Peng YS, et al. Microalbuminuria screening for detecting chronic kidney disease in the general population. Ren Fail. 2013;35 (5):607-614.
5. American Diabetes Association. Standards of medical care in diabetes: 2013. Diabetes Care. 2013;36 (suppl 1):S11-S66.
6. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease. Am J Kidney Dis. 2002;39 (2) (suppl 1):S1-S266.
7. Chadban S, Howell M, Twigg S, et al. The CARI guidelines: assessment of kidney function in type 2 diabetes. Nephrology (Carlton). 2010;15 (15) (suppl 1):S146-S161.
8. Polkinghorne KR. Detection and measurement of urinary protein. Curr Opin Nephrol Hypertens. 2006;15 (6):625-630. (Pubitemid 44607435)
9. Torffvit O, Agardh CD. The impact ofmetabolic and blood pressure control on incidence and progression of nephropathy. J Diabetes Complications. 2001;15 (6):307-313.
10. Price CP, Newall RG, Boyd JC. Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria. Clin Chem. 2005;51 (9):1577-1586. (Pubitemid 41233090)
11. Ewald B, Attia J. Which test to detect microalbuminuria in diabetic patients? a systematic review. Aust FamPhysician. 2004;33 (7):565-567,571.
12. Gansevoort RT, Verhave JC, Hillege HL, et al PREVEND Study Group. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int Suppl. 2005;67 (94):S28-S35.
13. Incerti J, Zelmanovitz T, Camargo JL, Gross JL, de Azevedo MJ. Evaluation of tests fomicroalbuminuria screening in patients with diabetes. Nephrol Dial Transplant. 2005;20 (11):2402-2407. (Pubitemid 41548863)
14. Bakker AJ. Detection ofmicroalbuminuria. Diabetes Care. 1999;22 (2):307-313.
15. CaramoriML, Fioretto P, Mauer M. Enhancing the predictive value of urinary albumin for diabetic nephropathy. J AmSoc Nephrol. 2006;17 (2):339-352.
16. Naresh CN, Hayen A, Craig JC, Chadban SJ. Day-to-day variability in spot urine protein-creatinine ratio measurements. Am J Kidney Dis. 2012;60 (4):561-566.
17. Lum G. How effective are screening tests for microalbuminuria in random urine specimens? Ann Clin Lab Sci. 2000;30 (4):406-411.
18. Sampaio E, Delfino VD. Assessing albuminuria in spot morning samples from diabetic patients. Arq Bras Endocrinol Metabol. 2008;52 (9):1482-1488.
19. Wiegmann TB, Chonko AM, BarnardMJ, et al. Comparison of albumin excretion rate obtained with different times of collection. Diabetes Care. 1990;13 (8):864-871. (Pubitemid 20331541)
20. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care. 1997;20 (4):516-519. (Pubitemid 27143407)
21. Ahn CW, Song YD, Kim JH, et al. The validity of random urine specimen albumin measurement as a screening test for diabetic nephropathy. Yonsei Med J. 1999;40 (1):40-45.
22. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med ResMethodol. 2003;3:25. doi:10.1186/1471-2288-3-25.
23. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56 (11):1129-1135. (Pubitemid 37386338)
24. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 1994;309 (6965):1351-1355. (Pubitemid 24345976)
25. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882-893. (Pubitemid 41115772)
26. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58 (10):982-990. (Pubitemid 41316441)
27. Hamza TH, van Houwelingen HC, Stijnen T. The binomial distribution ofmeta-analysis was preferred to model within-study variability. J Clin Epidemiol. 2008;61 (1):41-51. (Pubitemid 350236698)
28. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20 (19):2865-2884. (Pubitemid 32923212)
29. Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282 (11):1061-1066. (Pubitemid 29436454)
30. Bouhanick B, Berrut G, Chameau AM, et al. Predictive value of testing random urine sample to detect microalbuminuria in diabetic subjects during outpatient visit. Diabete Metab. 1992;18 (1):54-58.
31. Schwab SJ, Dunn FL, Feinglos MN. Screening for microalbuminuria. Diabetes Care. 1992;15 (11):1581-1584.
32. NgWY, Lui KF, ThaiAC. Evaluation of a rapid screening test formicroalbuminuria with a spot measurement of urine albumin-creatinine ratio. Ann Acad Med Singapore. 2000;29 (1):62-65.
33. Eshøj O, Feldt-Rasmussen B, Larsen ML, Mogensen EF. Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria. Diabet Med. 1987;4 (6):531-533. (Pubitemid 17163029)
34. Chaiken RL, Khawaja R, BardM, Eckert-Norton M, Banerji MA, Lebovitz HE. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Diabetes Care. 1997;20 (5):709-713. (Pubitemid 27202517)
35. Houlihan CA, Tsalamandris C, Akdeniz A, Jerums G. Albumin to creatinine ratio. Am J Kidney Dis. 2002;39 (6):1183-1189.
36. Gyamlani GG, Bergstralh EJ, Slezak JM, Larson TS. Urinary albumin to osmolality ratio predicts 24-hour urine albumin excretion in diabetes mellitus. Am J Kidney Dis. 2003;42 (4):685-692. (Pubitemid 37187368)
37. Valizadeh M, Nasser Farahmand A, Mousavi Nasab N, Tabatabaei-Malazy O. Determining the value of albumin to creatinine ratio in a single morning sample, compared to the 24-hour urinary albumin excretion test, for determining micro-albuminuria in diabetic patients. Iran J Diabetes Lipid Disord. 2009;8 (1):27-36.
38. Scheid DC, McCarthy LH, Lawler FH, Hamm RM, Reilly KE. Screening formicroalbuminuria to prevent nephropathy in patients with diabetes. J Fam Pract. 2001;50 (8):661-668. (Pubitemid 32757842)
39. Hutchison AS, Paterson KR. Collecting urine for microalbumin assay. Diabet Med. 1988;5 (6):527-532.
40. Patel A, MacMahon S, Chalmers J, et al ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370 (9590):829-840. (Pubitemid 47362321)
41. . Ismail-Beigi F, Craven TE, O'Connor PJ, et al ACCORD Study Group. Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. Kidney Int. 2012;81 (6):586-594.